COLL Stock Summary and Trading Ideas (Collegium Pharmaceutical | NASDAQ:COLL)

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Collegium Pharmaceutical trades on the NASDAQ stock market under the symbol COLL.

As of April 10, 2026, COLL stock price climbed to $35.47 with 488,545 million shares trading.

COLL has a beta of 1.29, meaning it tends to be more sensitive to market movements. COLL has a correlation of 0.19 to the broad based SPY ETF.

COLL has a market cap of $1.15 billion. This is considered a Small Cap stock.

Last quarter Collegium Pharmaceutical reported $205 million in Revenue and $2.04 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.05.

In the last 3 years, COLL traded as high as $50.79 and as low as $20.83.

The top ETF exchange traded funds that COLL belongs to (by Net Assets): IJR, VTI, IWM, VXF, AVUV.

COLL has outperformed the market in the last year with a price return of +34.5% while the SPY ETF gained +25.2%. However, in the short term, COLL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -22.1% vs -1.8% return in SPY. But in the last 2 weeks, COLL shares have fared better than the market returning +6.1% compared to SPY +5.3%.

COLL support price is $34.23 and resistance is $36.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COLL shares will trade within this expected range on the day.